Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest.

Expiratory flow limitation promotes dynamic hyperinflation during exercise in chronic obstructive pulmonary disease (COPD) patients with a consequent reduction in inspiratory capacity (IC), limiting their exercise tolerance. Therefore, the exercise capacity of patients with tidal expiratory flow limitation (FL) at rest should depend on the magnitude of IC. The presented study was designed to evaluate the role of FL on the relationship between resting IC, other respiratory function variables and exercise performance in COPD patients. Fifty-two patients were included in the study. Negative expiratory pressure (NEP) uptake (VO2,max) were measured during an incremental symptom-limited cycle exercise. Twenty-nine patients were FL at rest. The IC was normal in all non-FL patients, while in most FL subjects it was decreased. Both WRmax and VO2,max were lower in FL patients (p<0.001, each). A close relationship of WRmax and O2,max to IC was found (r=0.73 and 0.75, respectively; p<0.0001, each). In the whole group, stepwise regression analysis selected IC and forced expiratory volume in one second (FEV1)/forced vital capacity (FVC) (% predicted) as the only significant contributors to exercise tolerance. Subgroup analysis showed that IC was the sole predictor in FL patients, and FEV1/FVC in non-FL patients. Detection of flow limitation provides useful information on the factors that influence exercise capacity in chronic obstructive pulmonary disease patients. Accordingly, in patients with flow limitation, inspiratory capacity appears as the best predictor of exercise tolerance, reflecting the presence of dynamic hyperinflation.

[1]  R. Zeballos,et al.  Clinical exercise testing. , 2001, Clinics in chest medicine.

[2]  D. O’Donnell,et al.  Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[3]  J. Fozard,et al.  Determinants of maximal inspiratory pressure. The Baltimore Longitudinal Study of Aging. , 1998, American journal of respiratory and critical care medicine.

[4]  H. Gautier,et al.  Exercise limitation in obstructive lung disease. , 1998, Chest.

[5]  T. Similowski,et al.  Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients. , 1998, The European respiratory journal.

[6]  C. Chrusch,et al.  Mechanisms by which COPD affects exercise tolerance. , 1998, American journal of respiratory and critical care medicine.

[7]  C. Lisboa,et al.  Effect of inspiratory muscle training with an intermediate load on inspiratory power output in COPD. , 1998, The European respiratory journal.

[8]  M. Pichot,et al.  Expiratory flow limitation in COPD patients after single lung transplantation. , 1997, American journal of respiratory and critical care medicine.

[9]  M. Cosio,et al.  Detection of expiratory flow limitation during exercise in COPD patients. , 1997, Journal of applied physiology.

[10]  M. Decramer,et al.  Peripheral muscle weakness contributes to exercise limitation in COPD. , 1996, American journal of respiratory and critical care medicine.

[11]  N. Jones,et al.  Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. , 1995, American journal of respiratory and critical care medicine.

[12]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[13]  N. Koulouris,et al.  A simple method to detect expiratory flow limitation during spontaneous breathing. , 1995, The European respiratory journal.

[14]  N. Koulouris,et al.  Detection of expiratory flow limitation during mechanical ventilation. , 1994, American journal of respiratory and critical care medicine.

[15]  T. Beroíza,et al.  Inspiratory muscle training in chronic airflow limitation: comparison of two different training loads with a threshold device. , 1994, The European respiratory journal.

[16]  D. O’Donnell,et al.  Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. , 1993, The American review of respiratory disease.

[17]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[18]  J E Cotes,et al.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[19]  A. Miller,et al.  Lung function testing: selection of reference values and interpretative strategies. , 1992, The American review of respiratory disease.

[20]  G. Hommel A stagewise rejective multiple test procedure based on a modified Bonferroni test , 1988 .

[21]  M. Lebowitz,et al.  Changes in the normal maximal expiratory flow-volume curve with growth and aging. , 1983, The American review of respiratory disease.

[22]  J. Milic-Emili,et al.  Breathing pattern and hypercapnia in patients with obstructive pulmonary disease. , 1980, The American review of respiratory disease.

[23]  A. Grassino,et al.  Control of breathing in patients with chronic obstructive lung disease. , 1978, Clinical science and molecular medicine.

[24]  R. Edwards,et al.  Exercise Tolerance in Chronic Airway Obstruction1, 2 , 1971 .

[25]  H. Lange,et al.  Die arteriellen Blutgaspartialdrücke und ihre Beziehungen zu Alter und anthropometrischen Grössen , 1971 .

[26]  R. Goerg,et al.  [Arterial blood partial pressure as related to age and anthropometric data]. , 1971, Respiration; international review of thoracic diseases.

[27]  R. Edwards,et al.  Exercise tolerance in chronic airway obstruction. , 1971, The American review of respiratory disease.

[28]  R. Gilbert,et al.  DISABILITY IN PATIENTS WITH OBSTRUCTIVE PULMONARY DISEASE. , 1964, The American review of respiratory disease.